{ "story_id": "9da9824a3ebc805d78e60170f88301a7", "desk": "drm3", "revision": 1, "published_at": "2026-09-03T04:00:00.000Z", "content_hash": "1cacc7885999e917d7ef50cfc88b23679705d91f5f47a29392af49eeb6f1a06e", "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs", "basis": { "headline": "FDA Adds Boxed Warning to Iron Injection for Hypophosphatemia Risk", "dek": "FDA approves boxed warning for ferric carboxymaltose injection due to symptomatic hypophosphatemia risks.", "prose": "The FDA approved a label change for ferric carboxymaltose injection (Injectafer) to add a boxed warning for the risk of symptomatic hypophosphatemia. [^1]\n\nA US district judge granted an FDA request to stay a hearing in a lawsuit filed by Florida and Texas, moving the hearing to December 1. [^2]\n\nResearchers introduced FDARxBench, an expert-curated benchmark for evaluating document-grounded question-answering motivated by generic drug assessment. [^3]\n\nAn FDA Adverse Event Reporting System case series included reports of symptomatic hypophosphatemia that occurred after both single and multiple infusions of ferric carboxymaltose injection and resulted in hospitalizations. [^4]\n\nChronic hypophosphatemia associated with ferric carboxymaltose can also lead to osteomalacia (bone softening) and fractures. [^5]\n\nFerric carboxymaltose is an iron replacement therapy originally approved in 2013 for treating iron deficiency anemia in patients 1 year and older who cannot tolerate oral iron. [^6]\n\nThe delay is ostensibly to give more time for the government's internal review of the pill's safety data. [^7]\n\nThe lawsuit, brought by Florida and Texas, challenges the FDA's regulation of the abortion pill and its safety data. [^8]\n\nExperiments across proprietary and open-weight models revealed substantial gaps in factual grounding, long-context retrieval, and safe refusal behavior. [^9]\n\nThe benchmark was constructed in collaboration with FDA regulatory assessors to ensure high-quality, expert-curated QA examples. [^10]\n\nThe new hearing date of December 1 is after the November midterm elections. [^11]", "cited": "[{\"statement\":\"The FDA approved a label change for ferric carboxymaltose injection (Injectafer) to add a boxed warning for the risk of symptomatic hypophosphatemia.\",\"source\":\"MedpageToday\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T18:17:35.000Z\",\"publisher_count\":1,\"sources\":[\"MedpageToday\"]},{\"statement\":\"A US district judge granted an FDA request to stay a hearing in a lawsuit filed by Florida and Texas, moving the hearing to December 1.\",\"source\":\"lifesitenews.com\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T19:32:38.000Z\",\"publisher_count\":1,\"sources\":[\"lifesitenews.com\"]},{\"statement\":\"Researchers introduced FDARxBench, an expert-curated benchmark for evaluating document-grounded question-answering motivated by generic drug assessment.\",\"source\":\"arXiv.org\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T04:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"arXiv.org\"]},{\"statement\":\"An FDA Adverse Event Reporting System case series included reports of symptomatic hypophosphatemia that occurred after both single and multiple infusions of ferric carboxymaltose injection and resulted in hospitalizations.\",\"source\":\"MedpageToday\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T18:17:35.000Z\",\"publisher_count\":1,\"sources\":[\"MedpageToday\"]},{\"statement\":\"Chronic hypophosphatemia associated with ferric carboxymaltose can also lead to osteomalacia (bone softening) and fractures.\",\"source\":\"MedpageToday\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T18:17:35.000Z\",\"publisher_count\":1,\"sources\":[\"MedpageToday\"]},{\"statement\":\"Ferric carboxymaltose is an iron replacement therapy originally approved in 2013 for treating iron deficiency anemia in patients 1 year and older who cannot tolerate oral iron.\",\"source\":\"MedpageToday\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T18:17:35.000Z\",\"publisher_count\":1,\"sources\":[\"MedpageToday\"]},{\"statement\":\"The delay is ostensibly to give more time for the government's internal review of the pill's safety data.\",\"source\":\"lifesitenews.com\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T19:32:38.000Z\",\"publisher_count\":1,\"sources\":[\"lifesitenews.com\"]},{\"statement\":\"The lawsuit, brought by Florida and Texas, challenges the FDA's regulation of the abortion pill and its safety data.\",\"source\":\"lifesitenews.com\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T19:32:38.000Z\",\"publisher_count\":1,\"sources\":[\"lifesitenews.com\"]},{\"statement\":\"Experiments across proprietary and open-weight models revealed substantial gaps in factual grounding, long-context retrieval, and safe refusal behavior.\",\"source\":\"arXiv.org\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T04:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"arXiv.org\"]},{\"statement\":\"The benchmark was constructed in collaboration with FDA regulatory assessors to ensure high-quality, expert-curated QA examples.\",\"source\":\"arXiv.org\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-03T04:00:00.000Z\",\"publisher_count\":1,\"sources\":[\"arXiv.org\"]},{\"statement\":\"The new hearing date of December 1 is after the November midterm elections.\",\"source\":\"lifesitenews.com\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-01T19:32:38.000Z\",\"publisher_count\":1,\"sources\":[\"lifesitenews.com\"]}]", "kind": "news" }, "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature", "receipt": null, "receipt_note": "this revision predates receipt-keeping (before v0.37.0); the filed row lives in the record", "generation_chain": { "wire": { "stream": "fountain_news", "story_id": "a8822e79ede045f06ba35d425d6bbe55", "thread_id": "8378bc47b1fdb69ce1e2800c6e43a077", "thread_label": "FDA", "novelty": "UPDATE", "content_hash": "8d3d73884a5e9218b5479db15ab5e857ae869bb23726abf9007b5971cfccc8d7", "last_published_at": "2026-09-03T04:00:00.000Z", "read_receipt": { "slice_hash": "a6974819026a155e1c79c99aba73ab29d5f9d0aaa9cffb05e88a08023354a690", "cursor_from": "eyJ0cyI6IjIwMjYtMDktMDNUMDM6MzI6MTkuMDAwMDAwWiIsImlkIjoiNzMzZDYyYTFiNGQwMmJmNjYzNTk3YjhmN2JhZDBiZTIiLCJ2IjoiMSJ9", "cursor_to": "eyJ0cyI6IjIwMjYtMDktMDNUMDQ6MDk6MDAuMDAwMDAwWiIsImlkIjoiNjQ5MjI3ZDNmNWQyMGQ3NmI1ZTE1NGNhODNlMTI0ZTMiLCJ2IjoiMSJ9", "view": "v_fountain_news", "view_version": "1", "row_count": 100, "window_days": 3, "bytes_scanned": 12568115, "credits": 8, "price_per_100_rows": 8, "sig": "k4fkL1dHRNIJwSawY8K6wWBrTSdTIRM-buyZr56gcruiCoH5_IdJUeMzPH7d51ZTXAE0Qe6xSFoDys5UGTzsAw", "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE", "signer_path": "lakehouse/data-extract/v1", "alg": "Ed25519", "signed": true } }, "written_at": "2026-09-03T06:46:29.654Z" }, "cited_facts": [ { "statement": "The FDA approved a label change for ferric carboxymaltose injection (Injectafer) to add a boxed warning for the risk of symptomatic hypophosphatemia.", "source": "MedpageToday", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T18:17:35.000Z", "publisher_count": 1, "sources": [ "MedpageToday" ] }, { "statement": "A US district judge granted an FDA request to stay a hearing in a lawsuit filed by Florida and Texas, moving the hearing to December 1.", "source": "lifesitenews.com", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T19:32:38.000Z", "publisher_count": 1, "sources": [ "lifesitenews.com" ] }, { "statement": "Researchers introduced FDARxBench, an expert-curated benchmark for evaluating document-grounded question-answering motivated by generic drug assessment.", "source": "arXiv.org", "instrument": "News", "claim_key": null, "published_at": "2026-09-03T04:00:00.000Z", "publisher_count": 1, "sources": [ "arXiv.org" ] }, { "statement": "An FDA Adverse Event Reporting System case series included reports of symptomatic hypophosphatemia that occurred after both single and multiple infusions of ferric carboxymaltose injection and resulted in hospitalizations.", "source": "MedpageToday", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T18:17:35.000Z", "publisher_count": 1, "sources": [ "MedpageToday" ] }, { "statement": "Chronic hypophosphatemia associated with ferric carboxymaltose can also lead to osteomalacia (bone softening) and fractures.", "source": "MedpageToday", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T18:17:35.000Z", "publisher_count": 1, "sources": [ "MedpageToday" ] }, { "statement": "Ferric carboxymaltose is an iron replacement therapy originally approved in 2013 for treating iron deficiency anemia in patients 1 year and older who cannot tolerate oral iron.", "source": "MedpageToday", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T18:17:35.000Z", "publisher_count": 1, "sources": [ "MedpageToday" ] }, { "statement": "The delay is ostensibly to give more time for the government's internal review of the pill's safety data.", "source": "lifesitenews.com", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T19:32:38.000Z", "publisher_count": 1, "sources": [ "lifesitenews.com" ] }, { "statement": "The lawsuit, brought by Florida and Texas, challenges the FDA's regulation of the abortion pill and its safety data.", "source": "lifesitenews.com", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T19:32:38.000Z", "publisher_count": 1, "sources": [ "lifesitenews.com" ] }, { "statement": "Experiments across proprietary and open-weight models revealed substantial gaps in factual grounding, long-context retrieval, and safe refusal behavior.", "source": "arXiv.org", "instrument": "News", "claim_key": null, "published_at": "2026-09-03T04:00:00.000Z", "publisher_count": 1, "sources": [ "arXiv.org" ] }, { "statement": "The benchmark was constructed in collaboration with FDA regulatory assessors to ensure high-quality, expert-curated QA examples.", "source": "arXiv.org", "instrument": "News", "claim_key": null, "published_at": "2026-09-03T04:00:00.000Z", "publisher_count": 1, "sources": [ "arXiv.org" ] }, { "statement": "The new hearing date of December 1 is after the November midterm elections.", "source": "lifesitenews.com", "instrument": "News", "claim_key": null, "published_at": "2026-09-01T19:32:38.000Z", "publisher_count": 1, "sources": [ "lifesitenews.com" ] } ], "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true." }